Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ALKS · NASDAQ · Pharmaceuticals
$44.94−1.24 (−2.69%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Alkermes (ALKS) · oqro.io/stocks/ALKS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 3, 2026 · Filed Nov 4, 2026
Officer sold ~$94K of ALKS shares in the open marketSourcePlanned sale · Planned for Nov 3, 2026 · Notice filed Nov 3, 2026
Officer filed to sell about $94K of ALKS stockSourcePolitician trade (House) · Transaction Sep 29, 2026 · Disclosed Oct 12, 2026
Disclosed purchase of ALKS — reported range $1,001 - $15,000SourceInsider trade · Traded Oct 2, 2026 · Filed Oct 2, 2026
Officer sold ~$83K of ALKS shares in the open marketSourcePlanned sale · Planned for Oct 2, 2026 · Notice filed Oct 2, 2026
Officer filed to sell about $83K of ALKS stockSourcePolitician trade (House) · Transaction Jul 30, 2026 · Disclosed Sep 4, 2026
Disclosed purchase of ALKS — reported range $15,001 - $50,000SourceInsider trade · Traded Sep 3, 2026 · Filed Sep 3, 2026
Officer sold ~$98K of ALKS shares in the open marketSourceInsider trade · Traded Sep 1, 2026 · Filed Sep 1, 2026
Officer sold ~$423K of ALKS shares in the open marketSourceInsider trade · Traded Aug 17, 2026 · Filed Aug 17, 2026
Officer sold ~$340K of ALKS shares in the open marketSourceInsider trade · Traded Aug 17, 2026 · Filed Aug 17, 2026
Officer sold ~$33K of ALKS shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bridgewater Associates no longer reported ALKS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Frontier Capital Management Co LLC disclosed a new position in ALKS for Q2 2026SourceInsider trade · Traded Jul 6, 2026 · Filed Jul 6, 2026
Officer sold ~$110K of ALKS shares in the open marketSourceInsider trade · Traded Jul 1, 2026 · Filed Jul 1, 2026
Officer sold ~$427K of ALKS shares in the open marketSourceInsider trade · Traded Jul 1, 2026 · Filed Jul 1, 2026
Officer sold ~$36K of ALKS shares in the open marketSourceInsider trade · Traded Jun 12, 2026 · Filed Jun 13, 2026
Director sold ~$90K of ALKS shares in the open marketSourceInsider trade · Traded Jun 4, 2026 · Filed Jun 4, 2026
Officer sold ~$88K of ALKS shares in the open marketSourceInsider trade · Traded Jun 1, 2026 · Filed Jun 1, 2026
Officer sold ~$375K of ALKS shares in the open marketSourceInsider trade · Traded May 29, 2026 · Filed May 29, 2026
Officer sold ~$687K of ALKS shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 22, 2026
Segall Bryant & Hamill, LLC disclosed a reduced position in ALKS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bridgewater Associates disclosed a reduced position in ALKS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed an increased position in ALKS for Q1 2026Insider trade · Traded Apr 6, 2026 · Filed Apr 6, 2026
Officer sold ~$70K of ALKS shares in the open marketSourceInsider trade · Traded Apr 1, 2026 · Filed Apr 1, 2026
Officer sold ~$320K of ALKS shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Mar 16, 2026
Avoro Capital Advisors LLC disclosed a reduced position in ALKS for Q4 2025SourceInsider trade · Traded Mar 2, 2026 · Filed Mar 5, 2026
Officer sold ~$267K of ALKS shares in the open marketSourceInsider trade · Traded Mar 2, 2026 · Filed Mar 5, 2026
Officer sold ~$202K of ALKS shares in the open marketSourceInsider trade · Traded Mar 2, 2026 · Filed Mar 5, 2026
Officer sold ~$180K of ALKS shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Paradigm Biocapital Advisors LP no longer reported ALKS for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Baker Bros. Advisors LP disclosed an increased position in ALKS for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Bridgewater Associates disclosed a new position in ALKS for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Deep Track Capital, LP disclosed a new position in ALKS for Q4 2025Insider trade · Traded Jan 8, 2026 · Filed Jan 8, 2026
Officer sold ~$150K of ALKS shares in the open marketSourceInsider trade · Traded Jan 2, 2026 · Filed Jan 2, 2026
Officer sold ~$112K of ALKS shares in the open marketSourceInsider trade · Traded Dec 3, 2025 · Filed Dec 5, 2025
Officer sold ~$112K of ALKS shares in the open marketSourceInsider trade · Traded Dec 1, 2025 · Filed Dec 1, 2025
Officer sold ~$117K of ALKS shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Baker Bros. Advisors LP disclosed an increased position in ALKS for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
RTW Investments, LP disclosed a reduced position in ALKS for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Paradigm Biocapital Advisors LP disclosed an increased position in ALKS for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Avoro Capital Advisors LLC disclosed a reduced position in ALKS for Q3 2025Insider trade · Traded Oct 15, 2025 · Filed Oct 15, 2025
Officer sold ~$284K of ALKS shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Paradigm Biocapital Advisors LP disclosed a new position in ALKS for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Baker Bros. Advisors LP disclosed an increased position in ALKS for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Frazier Life Sciences Management, L.P. disclosed an increased position in ALKS for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
RTW Investments, LP disclosed a reduced position in ALKS for Q2 2025Insider trade · Traded Jun 9, 2025 · Filed Jun 10, 2025
Officer sold ~$106K of ALKS shares in the open marketSourceInsider trade · Traded Jun 10, 2025 · Filed Jun 10, 2025
Officer sold ~$104K of ALKS shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Driehaus Capital Management LLC disclosed a new position in ALKS for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
RTW Investments, LP disclosed a reduced position in ALKS for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Baker Bros. Advisors LP disclosed an increased position in ALKS for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 2, 2025
Segall Bryant & Hamill, LLC disclosed a reduced position in ALKS for Q1 2025Insider trade · Traded Feb 28, 2025 · Filed Feb 28, 2025
Officer sold ~$66K of ALKS shares in the open marketSourceInsider trade · Traded Feb 25, 2025 · Filed Feb 25, 2025
Officer sold ~$132K of ALKS shares in the open marketSourceInsider trade · Traded Feb 20, 2025 · Filed Feb 20, 2025
Officer sold ~$47K of ALKS shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 18, 2025
Frazier Life Sciences Management, L.P. disclosed an increased position in ALKS for Q4 2024SourceInsider trade · Traded Dec 9, 2024 · Filed Dec 10, 2024
Officer sold ~$1.96M of ALKS shares in the open marketSourceInsider trade · Traded Dec 9, 2024 · Filed Dec 10, 2024
Director sold ~$86K of ALKS shares in the open marketSourceInsider trade · Traded Dec 5, 2024 · Filed Dec 5, 2024
Officer sold ~$290K of ALKS shares in the open marketSourceInsider trade · Traded Dec 4, 2024 · Filed Dec 4, 2024
Officer sold ~$442K of ALKS shares in the open marketSourceInsider trade · Traded Nov 27, 2024 · Filed Nov 27, 2024
Officer sold ~$152K of ALKS shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 15, 2024
Frazier Life Sciences Management, L.P. disclosed a new position in ALKS for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
RTW Investments, LP disclosed a reduced position in ALKS for Q3 2024SourceInsider trade · Traded Nov 11, 2024 · Filed Nov 12, 2024
Officer sold ~$1.77M of ALKS shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deep Track Capital, LP disclosed an increased position in ALKS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Avoro Capital Advisors LLC no longer reported ALKS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Holocene Advisors, LP disclosed an increased position in ALKS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Driehaus Capital Management LLC disclosed an increased position in ALKS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
Segall Bryant & Hamill, LLC disclosed a reduced position in ALKS for Q2 2026SourceInsider trade · Traded Aug 3, 2026 · Filed Aug 3, 2026
Director sold ~$2.24M of ALKS shares in the open marketSourceInsider trade · Traded Aug 3, 2026 · Filed Aug 3, 2026
Officer sold ~$437K of ALKS shares in the open marketSourceInsider trade · Traded Aug 3, 2026 · Filed Aug 3, 2026
Officer sold ~$99K of ALKS shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Avoro Capital Advisors LLC disclosed a reduced position in ALKS for Q1 2026SourceInsider trade · Traded May 4, 2026 · Filed May 5, 2026
Officer sold ~$68K of ALKS shares in the open marketSourceInsider trade · Traded May 1, 2026 · Filed May 2, 2026
Officer sold ~$301K of ALKS shares in the open marketSourceInsider trade · Traded Mar 3, 2026 · Filed Mar 5, 2026
Officer sold ~$61K of ALKS shares in the open marketSourceInsider trade · Traded Mar 2, 2026 · Filed Mar 5, 2026
Officer sold ~$60K of ALKS shares in the open marketSourceInsider trade · Traded Feb 2, 2026 · Filed Feb 3, 2026
Director sold ~$1.12M of ALKS shares in the open marketSourceInsider trade · Traded Feb 2, 2026 · Filed Feb 3, 2026
Director sold ~$999K of ALKS shares in the open marketSourceInsider trade · Traded Feb 2, 2026 · Filed Feb 3, 2026
Officer sold ~$171K of ALKS shares in the open marketSourceInsider trade · Traded Feb 2, 2026 · Filed Feb 3, 2026
Officer sold ~$134K of ALKS shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Frazier Life Sciences Management, L.P. disclosed a reduced position in ALKS for Q3 2025SourceInsider trade · Traded Nov 3, 2025 · Filed Nov 3, 2025
Officer sold ~$273K of ALKS shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Avoro Capital Advisors LLC disclosed an increased position in ALKS for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Driehaus Capital Management LLC disclosed an increased position in ALKS for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 12, 2025
Segall Bryant & Hamill, LLC disclosed an increased position in ALKS for Q2 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
RTW Investments, LP disclosed an increased position in ALKS for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Avoro Capital Advisors LLC disclosed a new position in ALKS for Q4 2024SourceInsider trade · Traded Feb 12, 2025 · Filed Feb 14, 2025
Officer sold ~$5.62M of ALKS shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Deep Track Capital, LP no longer reported ALKS for Q4 2024SourceInsider trade · Traded Feb 13, 2025 · Filed Feb 14, 2025
Officer sold ~$3.92M of ALKS shares in the open marketSourceInsider trade · Traded Feb 13, 2025 · Filed Feb 14, 2025
Officer sold ~$1.21M of ALKS shares in the open marketSourceInsider trade · Traded Feb 12, 2025 · Filed Feb 14, 2025
Officer sold ~$1.1M of ALKS shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 11, 2025
Segall Bryant & Hamill, LLC disclosed a reduced position in ALKS for Q4 2024SourceInsider trade · Traded Jan 30, 2025 · Filed Feb 1, 2025
Officer sold ~$3.23M of ALKS shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 8, 2024
Segall Bryant & Hamill, LLC disclosed a reduced position in ALKS for Q3 2024SourceInsider trade · Traded Nov 6, 2024 · Filed Nov 7, 2024
Officer sold ~$309K of ALKS shares in the open marketSource